Drugs & Targets Atlantic Health System forms partnership with NCI’s Cooperative Human Tissue Network May 19, 2023Vol.49 No.20
Letter To The Editor Gary Schwartz: Monica Bertagnolli is poised to be a visionary NIH director April 28, 2023Vol.49 No.17By Gary Schwartz
Clinical Roundup ImmunityBio, NCI open first cancer prevention study to assess vaccines for Lynch Syndrome April 28, 2023
White House After 7 months at NCI, Bertagnolli is about to be named NIH director April 21, 2023Vol.49 No.16By Paul Goldberg
White House Decline in cancer mortality rate must accelerate to reach Moonshot goal, NCI study finds April 21, 2023Vol.49 No.16By Jacquelyn Cobb
Conversation with The Cancer LetterFree Monica Bertagnolli’s Cancer Plan makes the most of her two roles: NCI director and leader of the National Cancer Program April 14, 2023Vol.49 No.15By Paul Goldberg and Matthew Bin Han Ong
Pragmatica-Lung, a landmark pragmatic trial with registrational intent, starts enrollment April 14, 2023Vol.49 No.15By Jacquelyn Cobb
NCI NCI Director Bertagnolli designs Cancer Plan to trigger national conversation, transform cancer research and care April 07, 2023Vol.49 No.14By Matthew Bin Han Ong
Cancer History ProjectFree ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved March 24, 2023Vol.49 No.12By Paul Goldberg
